骨髓微环境来源的细胞外基质降解酶影响B细胞急性淋巴细胞白血病进展
该研究探讨骨髓微环境(BMM)中基质金属蛋白酶-9(MMP-9)对BCR-ABL1诱导的B细胞急性淋巴细胞白血病(B-ALL)进程的影响。结果表明,BMM中MMP-9缺失可延长荷瘤小鼠生存并减少白血病起始细胞,其机制为B-ALL细胞通过释放TNFα诱导间充质干细胞(MSC)经TNFR1-NF-κB通路表达MMP-9,进而降解细胞外基质(ECM)促进B-ALL侵袭。药理学抑制MMP-9或敲低TNF-α均可显著延长小鼠生存。
要点
- BMM中MMP-9缺失可延长B-ALL小鼠生存并减少白血病起始细胞。
- B-ALL细胞释放TNFα,经TNFR1-NF-κB通路诱导MSC表达MMP-9。
- 药理学抑制MMP-9或敲低TNF-α可显著延长B-ALL小鼠生存。
核心结论
- 白血病细胞来源的TNFα诱导BMM表达MMP-9,促进B-ALL进展。
- 抑制MMP-9可能作为现有疗法的辅助手段。
研究设计与样本
- 研究采用BCR-ABL1诱导的B-ALL小鼠模型,比较BMM中MMP-9缺陷与对照小鼠。
- 使用TNFR1缺陷受体小鼠及多种体内外实验验证机制。
主要发现
- BMM中MMP-9缺陷延长B-ALL小鼠生存并减少白血病起始细胞。
- BMM中MMP-9缺陷导致ECM蛋白降解减少和B-ALL侵袭减少。
- B-ALL细胞通过释放TNFα诱导MSC表达MMP-9,该过程依赖TNFR1下游NF-κB激活。
- 敲低B-ALL起始细胞中的TNF-α或药理学抑制MMP-9均显著延长B-ALL小鼠生存。
临床怎么用
- 抑制MMP-9可能作为B-ALL现有疗法的辅助策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Specific and reciprocal interactions with the bone marrow microenvironment (BMM) govern the course of hematological malignancies. Matrix metalloproteinase-9 (MMP-9), secreted by leukemia cells, facilitates tumor progression via remodeling of the extracellular matrix (ECM) of the BMM. Hypothesizing that leukemias may instruct the BMM to degrade the ECM, we show, that MMP-9-deficiency in the BMM prolongs survival of mice with BCR-ABL1-induced B-cell acute lymphoblastic leukemia (B-ALL) compared with controls and reduces leukemia-initiating cells. MMP-9-deficiency in the BMM leads to reduced degradation of proteins of the ECM and reduced invasion of B-ALL. Using various in vivo and in vitro assays, as well as recipient mice deficient for the receptor for tumor necrosis factor (TNF) α (TNFR1) we demonstrate that B-ALL cells induce MMP-9-expression in mesenchymal stem cells (MSC) and possibly other cells of the BMM via a release of TNFα. MMP-9-expression in MSC is mediated by activation of nuclear factor kappa B (NF-κB) downstream of TNFR1. Consistently, knockdown of TNF-α in B-ALL-initiating cells or pharmacological inhibition of MMP-9 led to significant prolongation of survival in mice with B-ALL. In summary, leukemia cell-derived Tnfα induced MMP-9-expression by the BMM promoting B-ALL progression. Inhibition of MMP-9 may act as an adjunct to existing therapies.
引用
- Verma D, Zanetti C, Godavarthy PS, et al. Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia. Leukemia. 2020. PMID: 31919471. doi:10.1038/s41375-019-0674-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。